How Do Medications for Weight Loss Actually Work
They seem to be the two non-negotiables in GLP-1-informed food formulation, in terms of what consumers both want and need
Weight loss can be challenging for many individuals, even when they maintain a well-balanced diet and exercise plan
GLP-1R activation of neuroprotective pathways in neurons, microglia and astrocytes has also been reported: improvements in overall cognition, learning and motor function potentially associated with GLP-1RA administration in Alzheimers disease and Parkinsons disease may be mediated not only by their amyloid pathology-ameliorating properties (A, tau and -synuclein), but also the suppression of Ca 2+ deregulation and endoplasmic reticulum stress, anti-inflammatory activity, blockage of oxidative stress, mitochondrial dysfunction and apoptosis pathways, enhancements in the neuronal insulin sensitivity and energy metabolism, functional improvements in autophagy and mitophagy, elevated brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis, and neurogenesis 36
The American Diabetes Association recommends that weight management with GLP-1 agonists be part of a comprehensive approach including nutritional counseling, physical activity, and behavioral support to optimize outcomes and maintain weight loss long-term
268 The latter includes both central homeostatic (energy-intake-focused) and non-homeostatic (reward-focused) regulation of food consumption in the hypothalamus and nucleus of the solitary tract, 268-271 influenced by a relatively small amount of GLP-1 that crosses the blood-brain barrier and, more notably, GLP-1 modulation of vagal afferent neurons
